Nothing Special   »   [go: up one dir, main page]

GB201317410D0 - Animal models and therapeutic molecules - Google Patents

Animal models and therapeutic molecules

Info

Publication number
GB201317410D0
GB201317410D0 GBGB1317410.7A GB201317410A GB201317410D0 GB 201317410 D0 GB201317410 D0 GB 201317410D0 GB 201317410 A GB201317410 A GB 201317410A GB 201317410 D0 GB201317410 D0 GB 201317410D0
Authority
GB
United Kingdom
Prior art keywords
animal models
therapeutic molecules
therapeutic
molecules
models
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1317410.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kymab Ltd
Original Assignee
Kymab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kymab Ltd filed Critical Kymab Ltd
Priority to GBGB1317410.7A priority Critical patent/GB201317410D0/en
Priority to GBGB1317447.9A priority patent/GB201317447D0/en
Publication of GB201317410D0 publication Critical patent/GB201317410D0/en
Priority to SG11201602236SA priority patent/SG11201602236SA/en
Priority to TW103134343A priority patent/TW201546284A/en
Priority to ES14781635T priority patent/ES2859373T3/en
Priority to AU2014330922A priority patent/AU2014330922A1/en
Priority to CA2925723A priority patent/CA2925723A1/en
Priority to EP20191651.7A priority patent/EP3794941B1/en
Priority to SG10201802295XA priority patent/SG10201802295XA/en
Priority to EP14781635.9A priority patent/EP3051942B1/en
Priority to NL2013554A priority patent/NL2013554B1/en
Priority to PCT/GB2014/052971 priority patent/WO2015049517A2/en
Priority to JP2016548441A priority patent/JP7133902B2/en
Priority to DE112014004537.3T priority patent/DE112014004537T5/en
Priority to CN201480054605.7A priority patent/CN105683365A/en
Priority to NL2015773A priority patent/NL2015773B1/en
Priority to US15/088,805 priority patent/US10149462B2/en
Priority to US16/216,666 priority patent/US10966412B2/en
Priority to JP2019220440A priority patent/JP6843953B2/en
Priority to US17/180,258 priority patent/US11399522B2/en
Priority to JP2021026065A priority patent/JP7179106B2/en
Priority to US17/878,628 priority patent/US20230157264A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
GBGB1317410.7A 2013-10-01 2013-10-01 Animal models and therapeutic molecules Ceased GB201317410D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GBGB1317410.7A GB201317410D0 (en) 2013-10-01 2013-10-01 Animal models and therapeutic molecules
GBGB1317447.9A GB201317447D0 (en) 2013-10-01 2013-10-02 Animal models and therapeutic molecules
CN201480054605.7A CN105683365A (en) 2013-10-01 2014-10-01 Animal models and therapeutic molecules
NL2013554A NL2013554B1 (en) 2013-10-01 2014-10-01 Animal models and therapeutic molecules.
DE112014004537.3T DE112014004537T5 (en) 2013-10-01 2014-10-01 Animal models and therapeutic molecules
ES14781635T ES2859373T3 (en) 2013-10-01 2014-10-01 Animal models and therapeutic molecules
AU2014330922A AU2014330922A1 (en) 2013-10-01 2014-10-01 Animal models and therapeutic molecules
CA2925723A CA2925723A1 (en) 2013-10-01 2014-10-01 Animal models and therapeutic molecules
EP20191651.7A EP3794941B1 (en) 2013-10-01 2014-10-01 Animal models and therapeutic molecules
SG10201802295XA SG10201802295XA (en) 2013-10-01 2014-10-01 Animal Models and Therapeutic Molecules
EP14781635.9A EP3051942B1 (en) 2013-10-01 2014-10-01 Animal models and therapeutic molecules
SG11201602236SA SG11201602236SA (en) 2013-10-01 2014-10-01 Animal models and therapeutic molecules
PCT/GB2014/052971 WO2015049517A2 (en) 2013-10-01 2014-10-01 Animal models and therapeutic molecules
JP2016548441A JP7133902B2 (en) 2013-10-01 2014-10-01 Animal models and therapeutic molecules
TW103134343A TW201546284A (en) 2013-10-01 2014-10-01 Animal models and therapeutic molecules
NL2015773A NL2015773B1 (en) 2013-10-01 2015-11-11 Animal models and therapeutic molecules.
US15/088,805 US10149462B2 (en) 2013-10-01 2016-04-01 Animal models and therapeutic molecules
US16/216,666 US10966412B2 (en) 2013-10-01 2018-12-11 Animal models and therapeutic molecules
JP2019220440A JP6843953B2 (en) 2013-10-01 2019-12-05 Animal models and therapeutic molecules
US17/180,258 US11399522B2 (en) 2013-10-01 2021-02-19 Animal models and therapeutic molecules
JP2021026065A JP7179106B2 (en) 2013-10-01 2021-02-22 Animal models and therapeutic molecules
US17/878,628 US20230157264A1 (en) 2013-10-01 2022-08-01 Animal models and therapeutic molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1317410.7A GB201317410D0 (en) 2013-10-01 2013-10-01 Animal models and therapeutic molecules

Publications (1)

Publication Number Publication Date
GB201317410D0 true GB201317410D0 (en) 2013-11-13

Family

ID=49585158

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1317410.7A Ceased GB201317410D0 (en) 2013-10-01 2013-10-01 Animal models and therapeutic molecules
GBGB1317447.9A Ceased GB201317447D0 (en) 2013-10-01 2013-10-02 Animal models and therapeutic molecules

Family Applications After (1)

Application Number Title Priority Date Filing Date
GBGB1317447.9A Ceased GB201317447D0 (en) 2013-10-01 2013-10-02 Animal models and therapeutic molecules

Country Status (1)

Country Link
GB (2) GB201317410D0 (en)

Also Published As

Publication number Publication date
GB201317447D0 (en) 2013-11-13

Similar Documents

Publication Publication Date Title
SG10201802295XA (en) Animal Models and Therapeutic Molecules
HK1200872A1 (en) Animal models and therapeutic molecules
HK1222530A1 (en) Microclosures and related methods for skin treatment
ZA201601430B (en) Insecticidal proteins and methods for their use
IL245297A0 (en) Cancer models and associated methods
HK1217439A1 (en) Toxic aldehyde related diseases and treatment
ZA201509369B (en) Insecticidal proteins and methods for their use
GB2561352B (en) Animal models and therapeutic molecules
GB201320729D0 (en) Therapeutic compounds and their use
SI3063275T1 (en) Therapeutic nuclease-albumin fusions and methods
HK1254296A1 (en) Therapeutic compounds and uses thereof
DK3043763T3 (en) Stimulation and therapy device
HK1217092A1 (en) Therapeutic compounds and uses thereof
IL244214B (en) Thienopiperidine derivative and use thereof
DK2961830T3 (en) SKIN MODEL
GB201311361D0 (en) Compounds and their therapeutic use
HK1220323A1 (en) Animal models of cancer
EP2992759A4 (en) Atopic dermatitis model animal and use thereof
GB201308736D0 (en) Compounds and their therapeutic use
GB201317447D0 (en) Animal models and therapeutic molecules
GB201309498D0 (en) Novel diagnosis and therapy
GB2510146B (en) Combined grooming and massage device
GB201317804D0 (en) Therapeutic compounds and their use
GB201316173D0 (en) Compounds and their therapeutic use
EP2996684A4 (en) Therapeutic methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)